Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Lisata Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 22 | 21 | −1 |
| Shares | 680.8K | 684.8K | +4.00K (+0.6%) |
| Value | $2.51M | $1.46M | −$1.05M (−41.9%) |
New holders (3)
Institutions that held Lisata Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| IFP Advisors, Inc | 10 | $21 | 0.00% |
| JPMorgan Chase & Co | 8 | $17 | 0.00% |
| Steward Partners Investment Advisory, LLC | 6 | $13 | 0.00% |
Sold out (4)
Institutions that held Lisata Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Dimensional Fund Advisors LP | 14,951 | $55.3K |
| Tower Research Capital LLC (TRC) | 1,060 | $3.92K |
| FMR LLC | 1 | $4 |
| Valley National Advisers Inc | 2 | – |